Thanks MGK_2, I found what I was talking about. This article came out June 21, 2022 and the stock price ran up on rumors of talks with GSK. It peaked in the mid-$1.20s two weeks later with an equally quick pullback.

https://www.insiderfinancial.com/post/glaxos-...ver-target